| | Call Details | HeartWare International Earnings Conference Call (Q3 2009) Thu,
Nov 5, 2009, 8:00 am Eastern
| | About HeartWare International
(NasdaqGM:HTWR) |
| | HeartWare International, Inc., a medical device company, focuses on developing and commercializing a family of blood pumps that are surgically implanted to help augment blood circulation in patients suffering from chronic and end-stage heart failure. Its principle product includes the heartware ventricular assist system that is designed to provide circulatory support for patients with advanced heart failure. This system comprises a left ventricular assist device, related accessories, and surgical tools. The company is also developing the Miniaturized Ventricular Assist Device (MVAD). MVAD is in the development stage and is undergoing animal studies focused on minimally invasive implantation techniques. HeartWare International, Inc. is headquartered in Framingham, Massachusetts with an additional office in Sydney, Australia. |
| More
Info:
Quote
|
Profile
|
Reports
|
Research
|
Insider
|
Financials |
|